| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.704 | 0.006 | 0.704 | Vasodilator, peripheral | 0.35 0.074 DBMET02642 0.514 0.025 DBMET02644 0.28 0.108 DBMET02646 | ||
| 0.683 | 0.003 | 0.683 | Histamine H1 receptor antagonist | 0.367 0.005 DBMET02642 0.316 0.006 DBMET02644 0.134 0.028 DBMET02645 | ||
| 0.652 | 0.009 | 0.652 | Spasmolytic | 0.246 0.093 DBMET02642 0.494 0.024 DBMET02644 0.461 0.029 DBMET02645 0.395 0.041 DBMET02646 | ||
| 0.546 | 0.004 | 0.546 | Mediator release inhibitor | 0.115 0.053 DBMET02642 0.294 0.008 DBMET02644 0.116 0.051 DBMET02646 | ||
| 0.57 | 0.033 | 0.577 | Analgesic | 0.577 0.031 DBMET02644 0.318 0.128 DBMET02645 0.254 0.179 DBMET02646 | DBMET02644 | |
| 0.543 | 0.017 | 0.544 | Histamine release inhibitor | 0.253 0.153 DBMET02642 0.544 0.017 DBMET02644 0.529 0.02 DBMET02646 0.424 0.063 DBMET02649 | DBMET02644 | |
| 0.52 | 0.03 | 0.757 | Aldehyde oxidase inhibitor | 0.566 0.024 DBMET02644 0.757 0.005 DBMET02646 0.258 0.079 DBMET02649 | DBMET02646 | |
| 0.49 | 0.017 | 0.49 | Vasodilator, coronary | 0.234 0.15 DBMET02642 0.45 0.023 DBMET02644 0.229 0.155 DBMET02645 0.345 0.057 DBMET02646 | ||
| 0.441 | 0.005 | 0.441 | Antihistaminic | 0.123 0.042 DBMET02642 0.136 0.037 DBMET02644 0.166 0.028 DBMET02645 | ||
| 0.446 | 0.02 | 0.446 | Platelet antagonist | 0.235 0.079 DBMET02642 0.36 0.036 DBMET02644 0.201 0.1 DBMET02646 0.351 0.038 DBMET02649 | ||
| 0.42 | 0.005 | 0.42 | Histamine antagonist | 0.11 0.043 DBMET02642 0.121 0.038 DBMET02644 0.154 0.028 DBMET02645 | ||
| 0.444 | 0.039 | 0.444 | Antithrombotic | 0.195 0.184 DBMET02642 0.374 0.057 DBMET02644 0.232 0.141 DBMET02645 0.425 0.043 DBMET02646 | ||
| 0.401 | 0.006 | 0.401 | Antipruritic | 0.163 0.08 DBMET02642 0.219 0.037 DBMET02644 0.183 0.062 DBMET02646 | ||
| 0.404 | 0.028 | 0.404 | Cardiotonic | 0.211 0.109 DBMET02642 0.393 0.03 DBMET02644 0.182 0.137 DBMET02646 | ||
| 0.383 | 0.012 | 0.383 | Phospholipase C inhibitor | 0.213 0.036 DBMET02642 0.369 0.013 DBMET02644 0.178 0.064 DBMET02645 0.211 0.037 DBMET02646 0.222 0.032 DBMET02649 | ||
| 0.369 | 0.005 | 0.412 | Nav1.1 sodium channel blocker | 0.215 0.016 DBMET02642 0.412 0.004 DBMET02644 0.212 0.017 DBMET02645 0.129 0.042 DBMET02646 | DBMET02644 | |
| 0.378 | 0.025 | 0.378 | Anticonvulsant | 0.265 0.052 DBMET02644 0.173 0.104 DBMET02645 0.214 0.073 DBMET02646 | ||
| 0.373 | 0.022 | 0.373 | Platelet aggregation inhibitor | 0.225 0.065 DBMET02644 | ||
| 0.374 | 0.028 | 0.374 | Vasodilator | 0.295 0.05 DBMET02644 0.291 0.051 DBMET02645 | ||
| 0.399 | 0.058 | 0.461 | Thioredoxin glutathione reductase inhibitor | 0.461 0.037 DBMET02644 0.353 0.076 DBMET02645 | DBMET02644 | |
| 0.334 | 0.007 | 0.334 | Succinate dehydrogenase inhibitor | 0.236 0.028 DBMET02642 0.26 0.019 DBMET02644 0.331 0.007 DBMET02646 0.205 0.045 DBMET02649 | ||
| 0.369 | 0.048 | 0.463 | Apoptosis antagonist | 0.234 0.143 DBMET02642 0.297 0.087 DBMET02644 0.463 0.025 DBMET02645 0.249 0.129 DBMET02646 0.336 0.063 DBMET02649 | DBMET02645 | |
| 0.322 | 0.005 | 0.427 | Ca(v)2.2 blocker | 0.187 0.019 DBMET02642 0.427 0.004 DBMET02644 0.215 0.014 DBMET02645 | DBMET02644 | |
| 0.365 | 0.058 | 0.727 | Cholesterol antagonist | 0.303 0.089 DBMET02644 0.493 0.034 DBMET02645 0.727 0.006 DBMET02646 0.251 0.125 DBMET02649 | DBMET02646 | |
| 0.38 | 0.074 | 0.497 | Antiobesity | 0.497 0.038 DBMET02644 0.371 0.078 DBMET02645 0.252 0.154 DBMET02646 | DBMET02644 | |
| 0.392 | 0.096 | 0.484 | Cyclophilin D inhibitor | 0.484 0.055 DBMET02644 0.272 0.189 DBMET02645 0.297 0.165 DBMET02646 | DBMET02644 | |
| 0.303 | 0.009 | 0.303 | Nav1.3 sodium channel blocker | 0.244 0.015 DBMET02644 0.159 0.042 DBMET02646 | ||
| 0.295 | 0.005 | 0.295 | Calcium antagonist | 0.092 0.054 DBMET02642 0.169 0.018 DBMET02644 | ||
| 0.294 | 0.01 | 0.294 | Calcium channel blocker | 0.205 0.028 DBMET02644 0.196 0.032 DBMET02645 | ||
| 0.296 | 0.014 | 0.3 | Phospholipase A2 inhibitor | 0.141 0.085 DBMET02642 0.226 0.031 DBMET02644 0.3 0.014 DBMET02645 0.189 0.049 DBMET02646 0.277 0.017 DBMET02649 | DBMET02645 | |
| 0.293 | 0.016 | 0.293 | Nav1.2 sodium channel blocker | 0.233 0.025 DBMET02644 0.138 0.066 DBMET02645 0.176 0.044 DBMET02646 | ||
| 0.278 | 0.022 | 0.278 | Insulin sensitizer | 0.148 0.136 DBMET02642 0.258 0.03 DBMET02644 0.167 0.111 DBMET02646 0.235 0.044 DBMET02649 | ||
| 0.34 | 0.087 | 0.446 | Toll-Like receptor 7 agonist | 0.446 0.044 DBMET02644 | DBMET02644 | |
| 0.334 | 0.091 | 0.437 | Toll-Like receptor agonist | 0.437 0.047 DBMET02644 | DBMET02644 | |
| 0.253 | 0.013 | 0.279 | ATPase inhibitor | 0.171 0.069 DBMET02642 0.258 0.012 DBMET02644 0.279 0.008 DBMET02646 | DBMET02646 | |
| 0.255 | 0.019 | 0.255 | Anesthetic local | 0.114 0.071 DBMET02644 0.137 0.056 DBMET02646 | ||
| 0.288 | 0.054 | 0.288 | Interleukin agonist | 0.247 0.081 DBMET02644 0.211 0.11 DBMET02646 0.247 0.081 DBMET02649 | ||
| 0.263 | 0.038 | 0.263 | Non-steroidal antiinflammatory agent | 0.244 0.045 DBMET02644 0.203 0.068 DBMET02645 0.18 0.088 DBMET02646 | ||
| 0.222 | 0.006 | 0.222 | Macrophage migration inhibitory factor inhibitor | 0.07 0.067 DBMET02642 0.144 0.017 DBMET02644 0.131 0.021 DBMET02646 | ||
| 0.3 | 0.092 | 0.338 | Calcium channel activator | 0.297 0.095 DBMET02644 0.338 0.058 DBMET02646 | DBMET02646 | |
| 0.212 | 0.023 | 0.212 | Neurotrophic factor | 0.123 0.091 DBMET02642 0.205 0.025 DBMET02644 | ||
| 0.247 | 0.059 | 0.282 | Neuropeptide Y2 antagonist | 0.282 0.029 DBMET02644 0.184 0.15 DBMET02645 0.206 0.109 DBMET02646 0.267 0.041 DBMET02649 | DBMET02644 | |
| 0.219 | 0.035 | 0.219 | Acetylcholine M1 receptor antagonist | 0.121 0.106 DBMET02642 0.163 0.063 DBMET02644 0.186 0.049 DBMET02645 0.207 0.039 DBMET02646 | ||
| 0.185 | 0.005 | 0.201 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 DBMET02642 0.201 0.004 DBMET02644 0.18 0.007 DBMET02646 | DBMET02644 | |
| 0.184 | 0.006 | 0.184 | Calcium channel L-type blocker | 0.137 0.012 DBMET02644 | ||
| 0.184 | 0.014 | 0.184 | Multidrug resistance-associated protein 1 inhibitor | 0.098 0.083 DBMET02642 0.137 0.032 DBMET02644 0.113 0.058 DBMET02645 | ||
| 0.187 | 0.02 | 0.187 | Calcium channel (voltage-sensitive) blocker | 0.171 0.025 DBMET02644 | ||
| 0.188 | 0.023 | 0.295 | Cyclooxygenase 3 inhibitor | 0.118 0.079 DBMET02644 0.191 0.022 DBMET02646 0.295 0.006 DBMET02649 | DBMET02649 | |
| 0.163 | 0.002 | 0.163 | GABA uptake inhibitor | 0.07 0.007 DBMET02642 0.119 0.003 DBMET02644 0.039 0.027 DBMET02645 0.051 0.015 DBMET02646 | ||
| 0.194 | 0.036 | 0.333 | Alpha-N-acetylglucosaminidase inhibitor | 0.101 0.1 DBMET02642 0.273 0.019 DBMET02644 0.301 0.016 DBMET02646 0.333 0.013 DBMET02649 | DBMET02649 | |
| 0.238 | 0.084 | 0.238 | Hypoglycemic | |||
| 0.252 | 0.099 | 0.252 | Hypoxia-inducible factor 1 alpha inhibitor | 0.196 0.156 DBMET02644 0.234 0.116 DBMET02646 | ||
| 0.306 | 0.158 | 0.53 | 5 Hydroxytryptamine release inhibitor | 0.391 0.084 DBMET02644 0.53 0.024 DBMET02646 0.262 0.212 DBMET02649 | DBMET02646 | |
| 0.206 | 0.06 | 0.206 | Sigma receptor agonist | 0.124 0.109 DBMET02644 | ||
| 0.172 | 0.032 | 0.172 | Antibacterial (Helicobacter pylori) | 0.125 0.074 DBMET02644 0.123 0.077 DBMET02645 0.168 0.034 DBMET02646 | ||
| 0.217 | 0.078 | 0.267 | RNA-directed DNA polymerase inhibitor | 0.267 0.041 DBMET02646 | DBMET02646 | |
| 0.235 | 0.097 | 0.46 | 5 Hydroxytryptamine uptake stimulant | 0.356 0.024 DBMET02644 0.46 0.006 DBMET02646 0.259 0.072 DBMET02649 | DBMET02646 | |
| 0.149 | 0.015 | 0.223 | Analgesic, opioid | 0.077 0.052 DBMET02642 0.223 0.008 DBMET02644 0.13 0.019 DBMET02645 | DBMET02644 | |
| 0.227 | 0.093 | 0.35 | Tyrosine 3 hydroxylase inhibitor | 0.29 0.038 DBMET02644 0.35 0.016 DBMET02646 0.266 0.054 DBMET02649 | DBMET02646 | |
| 0.183 | 0.05 | 0.241 | Arachidonic acid antagonist | 0.156 0.081 DBMET02644 0.241 0.008 DBMET02646 | DBMET02646 | |
| 0.145 | 0.013 | 0.192 | Lanosterol 14 alpha demethylase inhibitor | 0.085 0.081 DBMET02642 0.192 0.005 DBMET02644 0.157 0.009 DBMET02646 | DBMET02644 | |
| 0.174 | 0.052 | 0.181 | Insulin secretagoues | 0.135 0.091 DBMET02644 0.181 0.047 DBMET02649 | DBMET02649 | |
| 0.127 | 0.013 | 0.155 | Dopamine uptake inhibitor | 0.101 0.018 DBMET02644 0.155 0.009 DBMET02646 | DBMET02646 | |
| 0.127 | 0.013 | 0.275 | Prostaglandin antagonist | 0.275 0.005 DBMET02644 | DBMET02644 | |
| 0.157 | 0.046 | 0.161 | Nav1.6 sodium channel blocker | 0.158 0.045 DBMET02644 0.161 0.043 DBMET02646 | DBMET02646 | |
| 0.15 | 0.041 | 0.407 | Cystathionine beta-synthase inhibitor | 0.183 0.029 DBMET02644 0.407 0.005 DBMET02646 0.136 0.047 DBMET02649 | DBMET02646 | |
| 0.111 | 0.005 | 0.118 | MDM2 inhibitor | 0.118 0.004 DBMET02644 0.08 0.02 DBMET02646 | DBMET02644 | |
| 0.222 | 0.12 | 0.422 | Lipoxygenase inhibitor | 0.248 0.102 DBMET02644 0.422 0.032 DBMET02646 | DBMET02646 | |
| 0.158 | 0.058 | 0.184 | Cell wall synthesis inhibitor | 0.184 0.038 DBMET02644 0.178 0.041 DBMET02645 0.162 0.054 DBMET02646 0.159 0.058 DBMET02649 | DBMET02644 | |
| 0.111 | 0.013 | 0.112 | Calcium channel T-type blocker | 0.112 0.012 DBMET02644 | DBMET02644 | |
| 0.141 | 0.043 | 0.167 | Calcium channel N-type blocker | 0.167 0.028 DBMET02644 0.12 0.063 DBMET02645 0.117 0.068 DBMET02649 | DBMET02644 | |
| 0.164 | 0.066 | 0.235 | Protein-tyrosine phosphatase inhibitor | 0.124 0.108 DBMET02644 0.235 0.035 DBMET02645 0.172 0.061 DBMET02646 0.141 0.088 DBMET02649 | DBMET02645 | |
| 0.251 | 0.153 | 0.557 | GABA C receptor rho-3 antagonist | 0.383 0.069 DBMET02644 0.557 0.013 DBMET02646 | DBMET02646 | |
| 0.095 | 0.003 | 0.095 | Prostacyclin agonist | 0.053 0.004 DBMET02642 | ||
| 0.103 | 0.015 | 0.136 | Cannabinoid CB1 receptor antagonist | 0.136 0.009 DBMET02644 0.106 0.015 DBMET02645 0.087 0.022 DBMET02646 | DBMET02644 | |
| 0.158 | 0.071 | 0.215 | Diuretic | 0.215 0.039 DBMET02644 0.146 0.081 DBMET02645 0.214 0.039 DBMET02646 | DBMET02644 | |
| 0.114 | 0.027 | 0.169 | Opioid delta receptor antagonist | 0.169 0.016 DBMET02644 | DBMET02644 | |
| 0.124 | 0.038 | 0.292 | Creatine kinase inhibitor | 0.18 0.014 DBMET02644 0.122 0.039 DBMET02645 0.292 0.004 DBMET02646 0.109 0.05 DBMET02649 | DBMET02646 | |
| 0.095 | 0.013 | 0.095 | Thromboxane antagonist | 0.075 0.023 DBMET02644 0.047 0.045 DBMET02645 0.091 0.014 DBMET02646 0.087 0.016 DBMET02649 | ||
| 0.101 | 0.02 | 0.11 | Carbamoyl phosphate synthetase inhibitor | 0.11 0.018 DBMET02644 0.065 0.038 DBMET02645 0.085 0.026 DBMET02646 | DBMET02644 | |
| 0.136 | 0.055 | 0.136 | Cell adhesion inhibitor | 0.097 0.095 DBMET02646 0.115 0.069 DBMET02649 | ||
| 0.106 | 0.026 | 0.142 | Cannabinoid receptor antagonist | 0.142 0.016 DBMET02644 0.091 0.033 DBMET02645 0.103 0.028 DBMET02646 | DBMET02644 | |
| 0.118 | 0.04 | 0.271 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.213 0.014 DBMET02644 0.271 0.008 DBMET02646 0.23 0.012 DBMET02649 | DBMET02646 | |
| 0.184 | 0.106 | 0.368 | Hypolipemic | 0.16 0.127 DBMET02645 0.368 0.031 DBMET02646 | DBMET02646 | |
| 0.115 | 0.038 | 0.141 | NMDA receptor antagonist | 0.141 0.027 DBMET02644 0.129 0.031 DBMET02646 | DBMET02644 | |
| 0.087 | 0.01 | 0.115 | Calcium channel P-type blocker | 0.115 0.004 DBMET02644 0.078 0.017 DBMET02646 | DBMET02644 | |
| 0.225 | 0.149 | 0.348 | Interleukin 2 agonist | 0.24 0.13 DBMET02644 0.252 0.116 DBMET02646 0.348 0.046 DBMET02649 | DBMET02649 | |
| 0.087 | 0.011 | 0.087 | Thromboxane A2 antagonist | 0.073 0.019 DBMET02644 0.05 0.036 DBMET02645 0.083 0.013 DBMET02646 0.08 0.015 DBMET02649 | ||
| 0.139 | 0.063 | 0.15 | NADPH oxidase inhibitor | 0.15 0.054 DBMET02644 0.138 0.064 DBMET02646 | DBMET02644 | |
| 0.146 | 0.071 | 0.231 | Lipid peroxidase inhibitor | 0.231 0.031 DBMET02644 0.171 0.055 DBMET02645 0.16 0.062 DBMET02646 | DBMET02644 | |
| 0.112 | 0.04 | 0.173 | Opioid antagonist | 0.173 0.02 DBMET02644 | DBMET02644 | |
| 0.195 | 0.123 | 0.311 | Superoxide dismutase inhibitor | 0.285 0.056 DBMET02644 0.311 0.047 DBMET02646 0.273 0.062 DBMET02649 | DBMET02646 | |
| 0.073 | 0.005 | 0.073 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.058 0.006 DBMET02644 0.033 0.026 DBMET02645 | ||
| 0.107 | 0.041 | 0.151 | Triose-phosphate isomerase inhibitor | 0.114 0.036 DBMET02644 0.151 0.02 DBMET02646 | DBMET02646 | |
| 0.078 | 0.013 | 0.092 | Thromboxane synthase inhibitor | 0.08 0.012 DBMET02644 0.092 0.008 DBMET02646 0.052 0.042 DBMET02649 | DBMET02646 | |
| 0.068 | 0.004 | 0.068 | Prostaglandin D2 agonist | 0.055 0.006 DBMET02642 | ||
| 0.162 | 0.099 | 0.162 | P-glycoprotein inhibitor | |||
| 0.124 | 0.061 | 0.207 | Cholesterol synthesis inhibitor | 0.145 0.047 DBMET02644 0.207 0.025 DBMET02646 | DBMET02646 | |
| 0.125 | 0.063 | 0.128 | Acetylcholine muscarinic antagonist | 0.096 0.095 DBMET02644 0.128 0.06 DBMET02646 | DBMET02646 | |
| 0.289 | 0.228 | 0.36 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.36 0.14 DBMET02644 0.319 0.187 DBMET02646 | DBMET02644 | |
| 0.176 | 0.116 | 0.179 | 5 Hydroxytryptamine 3E antagonist | 0.175 0.121 DBMET02644 0.179 0.107 DBMET02646 | DBMET02646 | |
| 0.082 | 0.024 | 0.165 | NMDA 2C receptor antagonist | 0.165 0.006 DBMET02644 0.104 0.014 DBMET02646 | DBMET02644 | |
| 0.078 | 0.02 | 0.128 | Opioid agonist | 0.128 0.009 DBMET02644 | DBMET02644 | |
| 0.159 | 0.104 | 0.267 | Anesthetic general | 0.199 0.075 DBMET02644 0.267 0.043 DBMET02646 | DBMET02646 | |
| 0.097 | 0.047 | 0.207 | NADH dehydrogenase inhibitor | 0.129 0.024 DBMET02644 0.207 0.01 DBMET02646 | DBMET02646 | |
| 0.112 | 0.062 | 0.128 | Acetylcholine release stimulant | 0.128 0.037 DBMET02644 | DBMET02644 | |
| 0.081 | 0.033 | 0.131 | Phospholipase D inhibitor | 0.098 0.016 DBMET02644 0.131 0.005 DBMET02645 0.075 0.043 DBMET02646 | DBMET02645 | |
| 0.069 | 0.023 | 0.15 | Dopamine D4 agonist | 0.15 0.009 DBMET02644 0.046 0.041 DBMET02646 | DBMET02644 | |
| 0.064 | 0.021 | 0.074 | Leukotriene C antagonist | 0.074 0.011 DBMET02644 0.057 0.038 DBMET02646 | DBMET02644 | |
| 0.081 | 0.037 | 0.141 | Leukotriene synthesis inhibitor | 0.141 0.011 DBMET02646 0.141 0.011 DBMET02649 | DBMET02649 | |
| 0.055 | 0.011 | 0.242 | Prostacyclin antagonist | 0.242 0.003 DBMET02649 | DBMET02649 | |
| 0.065 | 0.022 | 0.285 | Dopamine transporter inhibitor | 0.285 0.004 DBMET02646 0.139 0.007 DBMET02649 | DBMET02646 | |
| 0.177 | 0.135 | 0.368 | Immunostimulant | 0.273 0.087 DBMET02645 0.173 0.137 DBMET02646 0.368 0.059 DBMET02649 | DBMET02649 | |
| 0.087 | 0.046 | 0.087 | Cell adhesion molecule inhibitor | 0.077 0.057 DBMET02646 | ||
| 0.078 | 0.038 | 0.078 | Dopamine agonist | 0.075 0.04 DBMET02644 0.075 0.041 DBMET02646 | ||
| 0.088 | 0.048 | 0.119 | Opioid kappa receptor antagonist | 0.119 0.024 DBMET02644 0.088 0.047 DBMET02646 | DBMET02644 | |
| 0.045 | 0.007 | 0.19 | Prostaglandin D2 antagonist | 0.19 0.004 DBMET02644 | DBMET02644 | |
| 0.068 | 0.032 | 0.069 | Acetylcholine M5 receptor antagonist | 0.069 0.031 DBMET02644 | DBMET02644 | |
| 0.121 | 0.085 | 0.146 | Vanilloid 1 agonist | 0.146 0.042 DBMET02646 | DBMET02646 | |
| 0.045 | 0.012 | 0.057 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET02642 0.057 0.006 DBMET02644 | DBMET02644 | |
| 0.041 | 0.007 | 0.104 | Nociceptin (N/OFQ) receptor agonist | 0.104 0.004 DBMET02644 | DBMET02644 | |
| 0.125 | 0.092 | 0.202 | Mannose-6-phosphate isomerase inhibitor | 0.172 0.048 DBMET02644 0.202 0.029 DBMET02646 | DBMET02646 | |
| 0.097 | 0.065 | 0.114 | Glutamate (mGluR7) agonist | 0.114 0.037 DBMET02646 | DBMET02646 | |
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.048 DBMET02644 | ||
| 0.071 | 0.039 | 0.133 | Leukotriene antagonist | 0.06 0.051 DBMET02644 0.108 0.019 DBMET02646 0.133 0.013 DBMET02649 | DBMET02649 | |
| 0.096 | 0.064 | 0.155 | Electrolyte absorption antagonist | 0.119 0.037 DBMET02644 0.155 0.018 DBMET02646 | DBMET02646 | |
| 0.104 | 0.074 | 0.131 | Protein-tyrosine phosphatase 1B inhibitor | 0.103 0.075 DBMET02645 0.131 0.055 DBMET02646 0.106 0.072 DBMET02649 | DBMET02646 | |
| 0.049 | 0.021 | 0.463 | Leukotriene A4 hydrolase inhibitor | 0.039 0.025 DBMET02645 0.463 0.003 DBMET02649 | DBMET02649 | |
| 0.147 | 0.119 | 0.326 | Psychostimulant | 0.134 0.132 DBMET02644 0.285 0.047 DBMET02646 0.326 0.036 DBMET02649 | DBMET02649 | |
| 0.156 | 0.129 | 0.284 | Neurotrophic factor enhancer | 0.195 0.081 DBMET02644 0.284 0.023 DBMET02646 | DBMET02646 | |
| 0.049 | 0.022 | 0.155 | Glutamate (mGluR4) antagonist | 0.155 0.004 DBMET02644 | DBMET02644 | |
| 0.042 | 0.014 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET02644 0.043 0.013 DBMET02646 | DBMET02646 | |
| 0.082 | 0.055 | 0.102 | Ca(v)3.1 blocker | 0.102 0.021 DBMET02644 | DBMET02644 | |
| 0.041 | 0.015 | 0.055 | Carnitine palmitoyltransferase 1 inhibitor | 0.055 0.005 DBMET02644 | DBMET02644 | |
| 0.054 | 0.028 | 0.151 | Glycine transporter inhibitor | 0.151 0.005 DBMET02644 | DBMET02644 | |
| 0.096 | 0.07 | 0.096 | Alpha 2c adrenoreceptor antagonist | |||
| 0.076 | 0.05 | 0.076 | Acetylcholine M4 receptor antagonist | 0.075 0.052 DBMET02644 | ||
| 0.04 | 0.015 | 0.056 | Carnitine palmitoyltransferase inhibitor | 0.056 0.006 DBMET02644 | DBMET02644 | |
| 0.042 | 0.018 | 0.055 | Opioid delta receptor agonist | 0.055 0.011 DBMET02644 | DBMET02644 | |
| 0.045 | 0.022 | 0.056 | Heme oxygenase inhibitor | 0.056 0.008 DBMET02644 0.052 0.011 DBMET02646 | DBMET02644 | |
| 0.189 | 0.166 | 0.232 | Gastrin inhibitor | 0.232 0.102 DBMET02644 | DBMET02644 | |
| 0.042 | 0.019 | 0.06 | p53 inhibitor | 0.06 0.009 DBMET02644 | DBMET02644 | |
| 0.111 | 0.091 | 0.15 | Sphingosine 1-phosphate receptor 4 antagonist | 0.15 0.033 DBMET02644 0.135 0.049 DBMET02646 | DBMET02644 | |
| 0.062 | 0.043 | 0.089 | NMDA receptor glycine site agonist | 0.079 0.029 DBMET02644 0.089 0.023 DBMET02646 0.088 0.023 DBMET02649 | DBMET02646 | |
| 0.031 | 0.013 | 0.04 | Prostaglandin H2 antagonist | 0.04 0.005 DBMET02646 | DBMET02646 | |
| 0.054 | 0.036 | 0.054 | Alpha-mannosidase inhibitor | 0.052 0.039 DBMET02646 | ||
| 0.03 | 0.012 | 0.048 | Prostaglandin EP2 agonist | 0.048 0.006 DBMET02646 | DBMET02646 | |
| 0.066 | 0.049 | 0.083 | Glutamate (mGluR6) antagonist | 0.079 0.025 DBMET02644 0.083 0.021 DBMET02646 0.064 0.053 DBMET02649 | DBMET02646 | |
| 0.1 | 0.084 | 0.1 | 5 Hydroxytryptamine 2B antagonist | 0.094 0.091 DBMET02644 | ||
| 0.032 | 0.019 | 0.057 | Prostaglandin agonist | 0.057 0.009 DBMET02646 | DBMET02646 | |
| 0.102 | 0.093 | 0.104 | Cholinergic antagonist | 0.104 0.09 DBMET02646 | DBMET02646 | |
| 0.032 | 0.023 | 0.058 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.058 0.009 DBMET02644 0.038 0.017 DBMET02646 | DBMET02644 | |
| 0.098 | 0.089 | 0.102 | Nav1.5 sodium channel blocker | 0.102 0.082 DBMET02644 | DBMET02644 | |
| 0.051 | 0.043 | 0.077 | Leukotriene B4 antagonist | 0.077 0.016 DBMET02646 | DBMET02646 | |
| 0.059 | 0.051 | 0.16 | Dopamine D1 antagonist | 0.16 0.014 DBMET02646 | DBMET02646 | |
| 0.023 | 0.016 | 0.042 | Prostaglandin E2 agonist | 0.042 0.007 DBMET02646 | DBMET02646 | |
| 0.016 | 0.01 | 0.018 | Thromboxane A2 agonist | 0.018 0.007 DBMET02646 | DBMET02646 | |
| 0.054 | 0.049 | 0.073 | Pregnane X receptor antagonist | 0.073 0.011 DBMET02646 | DBMET02646 | |
| 0.045 | 0.041 | 0.049 | CC chemokine receptor 2B antagonist | 0.049 0.033 DBMET02644 | DBMET02644 | |
| 0.061 | 0.057 | 0.275 | Phenylalanine 4-hydroxylase inhibitor | 0.078 0.039 DBMET02644 0.189 0.008 DBMET02646 0.275 0.004 DBMET02649 | DBMET02649 | |
| 0.055 | 0.055 | 0.095 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.095 0.012 DBMET02644 | DBMET02644 | |
| 0.062 | 0.063 | 0.18 | Catalase inhibitor | 0.082 0.047 DBMET02644 0.09 0.043 DBMET02646 0.18 0.019 DBMET02649 | DBMET02649 | |
| 0.089 | 0.091 | 0.108 | Toll-Like receptor 4 antagonist | 0.108 0.058 DBMET02646 0.097 0.075 DBMET02649 | DBMET02646 | |
| 0.008 | 0.012 | 0.01 | Thromboxane agonist | 0.01 0.009 DBMET02646 | DBMET02646 | |
| 0.064 | 0.068 | 0.121 | Glycine receptor agonist | 0.121 0.012 DBMET02644 0.106 0.018 DBMET02646 | DBMET02644 | |
| 0.054 | 0.059 | 0.14 | NMDA receptor agonist | 0.071 0.035 DBMET02644 0.082 0.028 DBMET02646 0.14 0.009 DBMET02649 | DBMET02649 | |
| 0.023 | 0.029 | 0.035 | LFA antagonist | 0.035 0.011 DBMET02644 | DBMET02644 | |
| 0.094 | 0.1 | 0.101 | Acetylcholine antagonist | 0.101 0.091 DBMET02646 | DBMET02646 | |
| 0.077 | 0.083 | 0.204 | HIV-1 integrase (Overall Integration) inhibitor | 0.123 0.038 DBMET02644 0.204 0.011 DBMET02646 | DBMET02646 | |
| 0.077 | 0.084 | 0.268 | 5-Lipoxygenase inhibitor | 0.268 0.014 DBMET02646 | DBMET02646 | |
| 0.035 | 0.042 | 0.049 | Phosphorylase inhibitor | 0.046 0.033 DBMET02644 0.049 0.031 DBMET02646 | DBMET02646 | |
| 0.02 | 0.027 | 0.025 | Prostaglandin EP4 antagonist | 0.025 0.019 DBMET02646 | DBMET02646 | |
| 0.041 | 0.05 | 0.279 | Aldose reductase inhibitor | 0.279 0.005 DBMET02644 0.087 0.021 DBMET02646 | DBMET02644 | |
| 0.082 | 0.091 | 0.18 | GABA C receptor agonist | 0.18 0.025 DBMET02644 0.175 0.026 DBMET02646 | DBMET02644 | |
| 0.079 | 0.089 | 0.17 | Sphingomyelinase inhibitor | 0.17 0.017 DBMET02646 | DBMET02646 | |
| 0.069 | 0.08 | 0.076 | Viral attachment inhibitor | 0.076 0.06 DBMET02645 | DBMET02645 | |
| 0.083 | 0.095 | 0.097 | Alpha 2b adrenoreceptor antagonist | 0.097 0.077 DBMET02644 | DBMET02644 | |
| 0.037 | 0.05 | 0.116 | Glutamate (mGluR group III) antagonist | 0.116 0.005 DBMET02644 | DBMET02644 | |
| 0.087 | 0.1 | 0.299 | Mucolytic | 0.097 0.082 DBMET02644 0.113 0.062 DBMET02645 0.102 0.075 DBMET02646 0.299 0.004 DBMET02649 | DBMET02649 | |
| 0.052 | 0.065 | 0.06 | CDC25B inhibitor | 0.06 0.05 DBMET02646 | DBMET02646 | |
| 0.055 | 0.069 | 0.091 | Interferon inducer | 0.06 0.055 DBMET02644 0.091 0.016 DBMET02645 | DBMET02645 | |
| 0.066 | 0.082 | 0.145 | GABA B receptor agonist | 0.091 0.025 DBMET02644 0.136 0.005 DBMET02646 0.145 0.004 DBMET02649 | DBMET02649 | |
| 0.042 | 0.057 | 0.066 | Aconitate hydratase inhibitor | 0.053 0.034 DBMET02644 0.066 0.021 DBMET02646 | DBMET02646 | |
| 0.156 | 0.172 | 0.547 | 5 Hydroxytryptamine release stimulant | 0.271 0.08 DBMET02644 0.547 0.02 DBMET02646 | DBMET02646 | |
| 0.065 | 0.082 | 0.105 | Interferon agonist | 0.072 0.065 DBMET02644 0.105 0.025 DBMET02645 | DBMET02645 | |
| 0.123 | 0.141 | 0.163 | Platelet adhesion inhibitor | 0.163 0.094 DBMET02646 | DBMET02646 | |
| 0.025 | 0.043 | 0.05 | 5-Alpha-reductase inhibitor | 0.034 0.029 DBMET02644 0.05 0.019 DBMET02646 | DBMET02646 | |
| 0.009 | 0.027 | 0.025 | Integrin alphaVbeta6 antagonist | 0.025 0.004 DBMET02649 | DBMET02649 | |
| 0.049 | 0.068 | 0.09 | Opioid mu receptor antagonist | 0.09 0.035 DBMET02644 | DBMET02644 | |
| 0.027 | 0.046 | 0.054 | CC chemokine 3 receptor antagonist | 0.054 0.022 DBMET02644 | DBMET02644 | |
| 0.01 | 0.03 | 0.015 | Dipeptidyl peptidase VIII inhibitor | 0.015 0.01 DBMET02644 | DBMET02644 | |
| 0.044 | 0.065 | 0.422 | 5 Hydroxytryptamine uptake inhibitor | 0.422 0.005 DBMET02646 0.122 0.02 DBMET02649 | DBMET02646 | |
| 0.039 | 0.061 | 0.066 | Bombesin 2 receptor antagonist | 0.061 0.024 DBMET02644 0.066 0.021 DBMET02645 | DBMET02645 | |
| 0.038 | 0.061 | 0.063 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 DBMET02646 | DBMET02646 | |
| 0.055 | 0.079 | 0.129 | Glutamate decarboxylase inhibitor | 0.074 0.05 DBMET02644 0.129 0.018 DBMET02646 0.12 0.021 DBMET02649 | DBMET02646 | |
| 0.065 | 0.09 | 0.805 | Antiadrenergic | 0.805 0.004 DBMET02642 0.081 0.07 DBMET02646 | DBMET02642 | |
| 0.019 | 0.045 | 0.028 | Carnitine palmitoyltransferase 1A inhibitor | 0.028 0.021 DBMET02644 | DBMET02644 | |
| 0.063 | 0.089 | 0.805 | Adrenaline antagonist | 0.805 0.004 DBMET02642 0.079 0.069 DBMET02646 | DBMET02642 | |
| 0.033 | 0.059 | 0.06 | Nerve growth factor antagonist | 0.06 0.009 DBMET02644 0.04 0.036 DBMET02646 | DBMET02644 | |
| 0.033 | 0.059 | 0.049 | Kainate receptor agonist | 0.049 0.014 DBMET02644 0.049 0.015 DBMET02646 | DBMET02646 | |
| 0.047 | 0.074 | 0.108 | Phosphofructokinase-1 inhibitor | 0.108 0.029 DBMET02646 | DBMET02646 | |
| 0.092 | 0.119 | 0.253 | Estrogen antagonist | 0.253 0.008 DBMET02646 | DBMET02646 | |
| 0.077 | 0.104 | 0.13 | Glutamate release inhibitor | 0.101 0.041 DBMET02644 0.13 0.016 DBMET02646 | DBMET02646 | |
| 0.015 | 0.042 | 0.053 | Nociceptin (N/OFQ) receptor antagonist | 0.053 0.013 DBMET02644 | DBMET02644 | |
| 0.159 | 0.187 | 0.266 | DNA synthesis inhibitor | 0.266 0.057 DBMET02646 0.17 0.169 DBMET02649 | DBMET02646 | |
| 0.026 | 0.055 | 0.052 | Cholecystokinin B agonist | 0.052 0.015 DBMET02645 | DBMET02645 | |
| 0.091 | 0.122 | 0.238 | Toll-Like receptor 2 antagonist | 0.155 0.049 DBMET02646 0.238 0.011 DBMET02649 | DBMET02649 | |
| 0.062 | 0.093 | 0.09 | Vanilloid 4 agonist | 0.088 0.028 DBMET02644 0.09 0.026 DBMET02646 | DBMET02646 | |
| 0.065 | 0.097 | 0.221 | Glutathione S-transferase inhibitor | 0.088 0.05 DBMET02646 0.221 0.005 DBMET02649 | DBMET02649 | |
| 0.022 | 0.054 | 0.068 | NMDA receptor subunit 3A antagonist | 0.043 0.023 DBMET02644 0.068 0.015 DBMET02646 | DBMET02646 | |
| 0.067 | 0.099 | 0.174 | Aminopeptidase B inhibitor | 0.095 0.069 DBMET02644 0.118 0.054 DBMET02646 0.174 0.028 DBMET02649 | DBMET02649 | |
| 0.029 | 0.061 | 0.078 | NMDA receptor subunit 3B antagonist | 0.078 0.014 DBMET02646 | DBMET02646 | |
| 0.084 | 0.117 | 0.193 | DOPA decarboxylase inhibitor | 0.119 0.046 DBMET02644 0.193 0.008 DBMET02646 0.115 0.051 DBMET02649 | DBMET02646 | |
| 0.057 | 0.09 | 0.138 | GABA aminotransferase inhibitor | 0.098 0.028 DBMET02644 0.138 0.01 DBMET02646 | DBMET02646 | |
| 0.083 | 0.116 | 0.288 | Amylase inhibitor | 0.105 0.092 DBMET02644 0.288 0.02 DBMET02646 | DBMET02646 | |
| 0.043 | 0.076 | 0.064 | Sphingosine 1-phosphate receptor 5 agonist | 0.064 0.021 DBMET02644 | DBMET02644 | |
| 0.005 | 0.039 | 0.016 | Integrin beta2 antagonist | 0.016 0.006 DBMET02644 | DBMET02644 | |
| 0.074 | 0.109 | 0.198 | Ferrochelatase inhibitor | 0.198 0.023 DBMET02644 0.163 0.033 DBMET02646 | DBMET02644 | |
| 0.074 | 0.109 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.059 DBMET02649 | DBMET02649 | |
| 0.017 | 0.053 | 0.046 | Calcium-sensing receptor agonist | 0.025 0.02 DBMET02644 0.046 0.006 DBMET02645 | DBMET02645 | |
| 0.029 | 0.065 | 0.037 | Thymidine kinase inhibitor | 0.037 0.036 DBMET02644 | DBMET02644 | |
| 0.008 | 0.044 | 0.022 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 DBMET02644 0.015 0.013 DBMET02646 | DBMET02644 | |
| 0.054 | 0.091 | 0.123 | Glutamate dehydrogenase inhibitor | 0.082 0.043 DBMET02644 0.098 0.032 DBMET02646 0.123 0.022 DBMET02649 | DBMET02649 | |
| 0.114 | 0.151 | 0.195 | Interferon gamma antagonist | 0.195 0.043 DBMET02646 | DBMET02646 | |
| 0.039 | 0.077 | 0.061 | Acetylcholine M3 receptor antagonist | 0.061 0.04 DBMET02646 | DBMET02646 | |
| 0.013 | 0.051 | 0.043 | Kynurenine 3 monooxygenase inhibitor | 0.043 0.009 DBMET02644 0.029 0.016 DBMET02646 | DBMET02644 | |
| 0.017 | 0.056 | 0.034 | Peroxisome proliferator-activated receptor delta agonist | 0.034 0.023 DBMET02646 | DBMET02646 | |
| 0.105 | 0.144 | 0.131 | Mcl-1 antagonist | 0.131 0.111 DBMET02644 | DBMET02644 | |
| 0.032 | 0.072 | 0.06 | Plasminogen activator inhibitor antagonist | 0.05 0.032 DBMET02644 0.06 0.024 DBMET02646 | DBMET02646 | |
| 0.043 | 0.083 | 0.092 | Sphingosine 1-phosphate receptor 4 agonist | 0.092 0.029 DBMET02646 | DBMET02646 | |
| 0.058 | 0.099 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.045 DBMET02644 | DBMET02644 | |
| 0.05 | 0.091 | 0.106 | Aminopeptidase I inhibitor | 0.077 0.045 DBMET02644 0.085 0.038 DBMET02646 0.106 0.025 DBMET02649 | DBMET02649 | |
| 0.03 | 0.072 | 0.04 | Integrin alpha1beta1 antagonist | 0.037 0.032 DBMET02644 0.04 0.022 DBMET02649 | DBMET02649 | |
| 0.078 | 0.122 | 0.117 | Adenylate kinase inhibitor | 0.099 0.069 DBMET02644 0.117 0.046 DBMET02646 | DBMET02646 | |
| 0.018 | 0.062 | 0.038 | Fumarate hydratase inhibitor | 0.032 0.026 DBMET02644 0.038 0.02 DBMET02646 | DBMET02646 | |
| 0.026 | 0.07 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.016 DBMET02644 | DBMET02644 | |
| 0.01 | 0.056 | 0.021 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 DBMET02644 0.021 0.012 DBMET02646 | DBMET02646 | |
| 0.041 | 0.087 | 0.061 | Peroxisome proliferator-activated receptor gamma agonist | 0.061 0.057 DBMET02646 | DBMET02646 | |
| 0.018 | 0.065 | 0.044 | Phosphoglycerate kinase inhibitor | 0.044 0.017 DBMET02646 | DBMET02646 | |
| 0.036 | 0.085 | 0.071 | Biliverdin reductase inhibitor | 0.064 0.037 DBMET02644 0.071 0.032 DBMET02646 | DBMET02646 | |
| 0.019 | 0.069 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.008 DBMET02646 | DBMET02646 | |
| 0.11 | 0.161 | 0.334 | Amyloid beta precursor protein antagonist | 0.334 0.011 DBMET02645 | DBMET02645 | |
| 0.013 | 0.064 | 0.027 | Prostaglandin F2 alpha agonist | 0.027 0.011 DBMET02646 | DBMET02646 | |
| 0.161 | 0.213 | 0.497 | Transcription factor NF kappa B inhibitor | 0.497 0.045 DBMET02646 0.263 0.118 DBMET02649 | DBMET02646 | |
| 0.016 | 0.07 | 0.055 | Integrin alpha2beta1 antagonist | 0.055 0.004 DBMET02646 | DBMET02646 | |
| 0.067 | 0.121 | 0.292 | Expectorant | 0.292 0.009 DBMET02649 | DBMET02649 | |
| 0.125 | 0.18 | 0.174 | Catenin beta inhibitor | 0.174 0.06 DBMET02644 0.156 0.092 DBMET02646 0.143 0.123 DBMET02649 | DBMET02644 | |
| 0.022 | 0.079 | 0.07 | Glutamate (mGluR3) antagonist | 0.034 0.029 DBMET02644 0.07 0.006 DBMET02646 | DBMET02646 | |
| 0.011 | 0.068 | 0.039 | Leukotriene B4 receptor 1 antagonist | 0.039 0.012 DBMET02646 | DBMET02646 | |
| 0.011 | 0.068 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.009 DBMET02644 | DBMET02644 | |
| 0.01 | 0.068 | 0.05 | Glycine transporter 1 inhibitor | 0.05 0.015 DBMET02644 | DBMET02644 | |
| 0.022 | 0.079 | 0.04 | Opioid kappa receptor agonist | 0.04 0.034 DBMET02644 | DBMET02644 | |
| 0.018 | 0.076 | 0.138 | ATP citrate lysase inhibitor | 0.029 0.026 DBMET02644 0.138 0.003 DBMET02646 | DBMET02646 | |
| 0.064 | 0.127 | 0.212 | UDP-glucose 4-epimerase inhibitor | 0.212 0.017 DBMET02646 | DBMET02646 | |
| 0.167 | 0.231 | 0.189 | Caspase 3 stimulant | 0.189 0.187 DBMET02644 | DBMET02644 | |
| 0.011 | 0.075 | 0.027 | Beta 1 adrenoreceptor agonist | 0.027 0.01 DBMET02646 | DBMET02646 | |
| 0.037 | 0.101 | 0.302 | Adrenaline uptake inhibitor | 0.302 0.004 DBMET02646 | DBMET02646 | |
| 0.018 | 0.083 | 0.046 | Sigma receptor antagonist | 0.046 0.037 DBMET02646 | DBMET02646 | |
| 0.013 | 0.078 | 0.084 | Kainate receptor 2 antagonist | 0.084 0.006 DBMET02644 | DBMET02644 | |
| 0.028 | 0.093 | 0.054 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.038 DBMET02646 | DBMET02646 | |
| 0.029 | 0.095 | 0.043 | VCAM-1 antagonist | 0.043 0.017 DBMET02649 | DBMET02649 | |
| 0.029 | 0.095 | 0.043 | VCAM antagonist | 0.043 0.017 DBMET02649 | DBMET02649 | |
| 0.007 | 0.073 | 0.015 | Cholecystokinin A agonist | 0.015 0.012 DBMET02645 | DBMET02645 | |
| 0.01 | 0.077 | 0.024 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.024 0.023 DBMET02646 | DBMET02646 | |
| 0.029 | 0.096 | 0.052 | Carnitine palmitoyltransferase 1B inhibitor | 0.052 0.026 DBMET02644 | DBMET02644 | |
| 0.015 | 0.081 | 0.031 | Methionyl aminopeptidase 1 inhibitor | 0.031 0.025 DBMET02646 | DBMET02646 | |
| 0.049 | 0.117 | 0.088 | Beta 2 adrenoreceptor agonist | 0.088 0.005 DBMET02646 | DBMET02646 | |
| 0.039 | 0.107 | 0.069 | DNA helicase inhibitor | 0.052 0.043 DBMET02644 0.069 0.017 DBMET02649 | DBMET02649 | |
| 0.009 | 0.077 | 0.137 | Squalene synthetase inhibitor | 0.049 0.015 DBMET02645 0.137 0.004 DBMET02646 | DBMET02646 | |
| 0.014 | 0.082 | 0.042 | GP IIb/IIIa receptor antagonist | 0.042 0.04 DBMET02644 | DBMET02644 | |
| 0.022 | 0.092 | 0.07 | Integrin alpha2 antagonist | 0.07 0.005 DBMET02646 | DBMET02646 | |
| 0.052 | 0.123 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | 0.067 0.062 DBMET02644 | DBMET02644 | |
| 0.041 | 0.113 | 0.08 | Adenine nucleotide translocase inhibitor | 0.08 0.009 DBMET02646 0.066 0.019 DBMET02649 | DBMET02646 | |
| 0.004 | 0.076 | 0.052 | Kainate receptor 1 antagonist | 0.052 0.005 DBMET02644 | DBMET02644 | |
| 0.039 | 0.111 | 0.214 | Histidine decarboxylase inhibitor | 0.07 0.05 DBMET02644 0.214 0.012 DBMET02646 0.135 0.022 DBMET02649 | DBMET02646 | |
| 0.048 | 0.12 | 0.072 | 5 Hydroxytryptamine 2C antagonist | 0.072 0.07 DBMET02646 | DBMET02646 | |
| 0.038 | 0.112 | 0.062 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.032 DBMET02644 0.062 0.026 DBMET02646 | DBMET02646 | |
| 0.019 | 0.093 | 0.099 | NMDA 2A receptor antagonist | 0.07 0.024 DBMET02644 0.099 0.013 DBMET02646 | DBMET02646 | |
| 0.007 | 0.083 | 0.016 | Cholecystokinin agonist | 0.016 0.015 DBMET02645 | DBMET02645 | |
| 0.024 | 0.101 | 0.04 | Glutamate (mGluR8) agonist | 0.04 0.022 DBMET02646 | DBMET02646 | |
| 0.027 | 0.104 | 0.054 | CC chemokine 4 receptor antagonist | 0.054 0.022 DBMET02644 | DBMET02644 | |
| 0.01 | 0.087 | 0.145 | Leukotriene D4 antagonist | 0.145 0.005 DBMET02649 | DBMET02649 | |
| 0.012 | 0.09 | 0.048 | Complement C3a chemotactic receptor antagonist | 0.048 0.028 DBMET02649 | DBMET02649 | |
| 0.049 | 0.127 | 0.08 | Exportin-1 inhibitor | 0.08 0.025 DBMET02646 | DBMET02646 | |
| 0.029 | 0.11 | 0.051 | CF transmembrane conductance regulator antagonist | 0.051 0.008 DBMET02646 | DBMET02646 | |
| 0.019 | 0.1 | 0.079 | Dopamine D5 agonist | 0.036 0.033 DBMET02644 0.079 0.006 DBMET02646 | DBMET02646 | |
| 0.063 | 0.145 | 0.184 | Estrogen receptor beta antagonist | 0.184 0.011 DBMET02646 | DBMET02646 | |
| 0.075 | 0.158 | 0.122 | Cytokine production inhibitor | 0.122 0.088 DBMET02646 | DBMET02646 | |
| 0.073 | 0.157 | 0.101 | Folate antagonist | 0.101 0.062 DBMET02649 | DBMET02649 | |
| 0.115 | 0.199 | 0.241 | Free radical scavenger | 0.241 0.072 DBMET02646 0.206 0.093 DBMET02649 | DBMET02646 | |
| 0.011 | 0.095 | 0.027 | Liver X receptor beta antagonist | 0.027 0.022 DBMET02646 | DBMET02646 | |
| 0.054 | 0.139 | 0.175 | Estrogen receptor alpha antagonist | 0.175 0.009 DBMET02646 | DBMET02646 | |
| 0.014 | 0.099 | 0.057 | Cholesterol ester transfer protein antagonist | 0.057 0.005 DBMET02646 | DBMET02646 | |
| 0.014 | 0.099 | 0.102 | Integrin antagonist | 0.102 0.016 DBMET02649 | DBMET02649 | |
| 0.032 | 0.117 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.038 DBMET02646 | DBMET02646 | |
| 0.118 | 0.204 | 0.218 | Neurotensin receptor agonist | 0.145 0.115 DBMET02644 0.178 0.052 DBMET02646 0.218 0.028 DBMET02649 | DBMET02649 | |
| 0.043 | 0.131 | 0.106 | Beta 3 adrenoreceptor antagonist | 0.106 0.013 DBMET02646 | DBMET02646 | |
| 0.019 | 0.108 | 0.051 | Estrogen-related receptor beta antagonist | 0.051 0.005 DBMET02646 | DBMET02646 | |
| 0.026 | 0.115 | 0.176 | Alcohol oxidase inhibitor | 0.176 0.008 DBMET02646 | DBMET02646 | |
| 0.062 | 0.151 | 0.151 | D-Ala-D-Ala ligase inhibitor | 0.084 0.057 DBMET02644 0.151 0.005 DBMET02646 | DBMET02646 | |
| 0.009 | 0.098 | 0.033 | Uridine phosphorylase inhibitor | 0.033 0.016 DBMET02646 | DBMET02646 | |
| 0.046 | 0.137 | 0.217 | Adrenaline agonist | 0.217 0.005 DBMET02646 | DBMET02646 | |
| 0.022 | 0.113 | 0.125 | Carbonic anhydrase XIV inhibitor | 0.125 0.006 DBMET02646 | DBMET02646 | |
| 0.062 | 0.155 | 0.094 | Adenylate cyclase inhibitor | 0.094 0.09 DBMET02646 | DBMET02646 | |
| 0.018 | 0.112 | 0.03 | Hedgehog signaling activator | 0.03 0.012 DBMET02646 | DBMET02646 | |
| 0.059 | 0.154 | 0.156 | Bromodomain-containing protein 2 inhibitor | 0.156 0.007 DBMET02646 | DBMET02646 | |
| 0.031 | 0.128 | 0.077 | Beta adrenoreceptor agonist | 0.077 0.005 DBMET02646 | DBMET02646 | |
| 0.117 | 0.217 | 0.281 | Antioxidant | 0.159 0.154 DBMET02644 0.173 0.139 DBMET02645 0.281 0.069 DBMET02646 0.222 0.1 DBMET02649 | DBMET02646 | |
| 0.013 | 0.113 | 0.073 | Thyroid hormone agonist | 0.073 0.003 DBMET02646 | DBMET02646 | |
| 0.035 | 0.136 | 0.115 | Angiotensin-converting enzyme inhibitor | 0.115 0.007 DBMET02649 | DBMET02649 | |
| 0.071 | 0.173 | 0.305 | Aldehyde dehydrogenase inhibitor | 0.305 0.011 DBMET02646 0.17 0.037 DBMET02649 | DBMET02646 | |
| 0.136 | 0.238 | 0.302 | Peptidyltransferase inhibitor | 0.198 0.102 DBMET02646 0.302 0.024 DBMET02649 | DBMET02649 | |
| 0.033 | 0.134 | 0.05 | CD45 antagonist | 0.047 0.042 DBMET02646 0.05 0.034 DBMET02649 | DBMET02649 | |
| 0.077 | 0.18 | 0.522 | Peroxidase inhibitor | 0.133 0.089 DBMET02644 0.522 0.008 DBMET02646 0.323 0.033 DBMET02649 | DBMET02646 | |
| 0.095 | 0.198 | 0.176 | Adenylate cyclase stimulant | 0.163 0.043 DBMET02644 0.176 0.029 DBMET02646 | DBMET02646 | |
| 0.018 | 0.122 | 0.046 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.046 0.014 DBMET02646 | DBMET02646 | |
| 0.012 | 0.116 | 0.083 | Kainate receptor antagonist | 0.083 0.009 DBMET02644 | DBMET02644 | |
| 0.016 | 0.12 | 0.051 | Toll-Like receptor 2 agonist | 0.051 0.023 DBMET02649 | DBMET02649 | |
| 0.022 | 0.131 | 0.042 | Glutamate (mGluR group III) agonist | 0.042 0.032 DBMET02646 | DBMET02646 | |
| 0.003 | 0.111 | 0.026 | Beta 3 adrenoreceptor agonist | 0.026 0.004 DBMET02646 | DBMET02646 | |
| 0.019 | 0.128 | 0.073 | Liver X receptor alpha agonist | 0.073 0.008 DBMET02646 | DBMET02646 | |
| 0.061 | 0.171 | 0.129 | AMP-activated protein kinase stimulant | 0.129 0.042 DBMET02646 | DBMET02646 | |
| 0.025 | 0.135 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.076 0.004 DBMET02646 | DBMET02646 | |
| 0.061 | 0.172 | 0.117 | Estrogen-related receptor beta agonist | 0.117 0.011 DBMET02646 | DBMET02646 | |
| 0.018 | 0.13 | 0.044 | Glutamate (mGluR3) agonist | 0.044 0.007 DBMET02646 0.032 0.024 DBMET02649 | DBMET02646 | |
| 0.084 | 0.195 | 0.45 | Dual specificity phosphatase 3 inhibitor | 0.45 0.01 DBMET02645 | DBMET02645 | |
| 0.058 | 0.172 | 0.126 | GABA C receptor rho-1 antagonist | 0.094 0.071 DBMET02644 0.126 0.035 DBMET02646 | DBMET02646 | |
| 0.054 | 0.169 | 0.147 | Chelator | 0.125 0.049 DBMET02644 0.147 0.036 DBMET02645 0.094 0.087 DBMET02646 0.109 0.066 DBMET02649 | DBMET02645 | |
| 0.004 | 0.12 | 0.045 | VLA-4 antagonist | 0.045 0.014 DBMET02649 | DBMET02649 | |
| 0.027 | 0.142 | 0.061 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.061 0.033 DBMET02646 | DBMET02646 | |
| 0.004 | 0.123 | 0.027 | Integrin alpha4 antagonist | 0.027 0.017 DBMET02649 | DBMET02649 | |
| 0.002 | 0.121 | 0.034 | Thyroid hormone beta agonist | 0.034 0.003 DBMET02646 | DBMET02646 | |
| 0.01 | 0.129 | 0.018 | Caspase 8 inhibitor | 0.018 0.016 DBMET02649 | DBMET02649 | |
| 0.017 | 0.138 | 0.034 | Purinergic P2Y2 antagonist | 0.034 0.023 DBMET02645 | DBMET02645 | |
| 0.022 | 0.143 | 0.051 | Argininosuccinate synthase inhibitor | 0.051 0.045 DBMET02646 | DBMET02646 | |
| 0.014 | 0.136 | 0.024 | Thymidine phosphorylase inhibitor | 0.024 0.023 DBMET02646 | DBMET02646 | |
| 0.028 | 0.152 | 0.075 | Sphingosine kinase 2 inhibitor | 0.075 0.018 DBMET02646 | DBMET02646 | |
| 0.034 | 0.158 | 0.11 | Cathepsin G inhibitor | 0.068 0.055 DBMET02644 0.11 0.03 DBMET02646 | DBMET02646 | |
| 0.048 | 0.173 | 0.094 | Prolactin inhibitor | 0.094 0.062 DBMET02646 | DBMET02646 | |
| 0.04 | 0.166 | 0.15 | Histamine N-methyltransferase inhibitor | 0.15 0.014 DBMET02646 | DBMET02646 | |
| 0.089 | 0.215 | 0.194 | GABA C receptor rho-2 antagonist | 0.123 0.119 DBMET02644 0.194 0.032 DBMET02646 | DBMET02646 | |
| 0.057 | 0.185 | 0.155 | GABA C receptor antagonist | 0.099 0.079 DBMET02644 0.155 0.028 DBMET02646 | DBMET02646 | |
| 0.008 | 0.136 | 0.05 | Sodium/glucose cotransporter 2 inhibitor | 0.05 0.006 DBMET02646 | DBMET02646 | |
| 0.016 | 0.144 | 0.052 | Erythropoietin receptor agonist | 0.052 0.021 DBMET02649 | DBMET02649 | |
| 0.024 | 0.152 | 0.04 | GABA B receptor antagonist | 0.04 0.036 DBMET02646 | DBMET02646 | |
| 0.048 | 0.179 | 0.145 | Uric acid excretion stimulant | 0.145 0.025 DBMET02646 | DBMET02646 | |
| 0.01 | 0.143 | 0.045 | Farnesoid X receptor agonist | 0.045 0.018 DBMET02646 | DBMET02646 | |
| 0.062 | 0.194 | 0.09 | T cell inhibitor | 0.09 0.038 DBMET02646 | DBMET02646 | |
| 0.011 | 0.147 | 0.158 | Estradiol 17 beta-dehydrogenase inhibitor | 0.158 0.005 DBMET02646 | DBMET02646 | |
| 0.129 | 0.265 | 0.243 | Calpain 2 inhibitor | 0.212 0.177 DBMET02644 0.243 0.154 DBMET02645 0.201 0.187 DBMET02649 | DBMET02645 | |
| 0.014 | 0.152 | 0.04 | Glycine transporter 2 inhibitor | 0.04 0.038 DBMET02646 | DBMET02646 | |
| 0.038 | 0.176 | 0.057 | Caspase 9 inhibitor | 0.057 0.054 DBMET02649 | DBMET02649 | |
| 0.027 | 0.166 | 0.049 | Squalene epoxidase inhibitor | 0.049 0.036 DBMET02646 | DBMET02646 | |
| 0.072 | 0.212 | 0.136 | Protein kinase stimulant | 0.136 0.079 DBMET02646 | DBMET02646 | |
| 0.01 | 0.15 | 0.036 | Sodium/glucose cotransporter inhibitor | 0.036 0.008 DBMET02646 | DBMET02646 | |
| 0.135 | 0.278 | 0.231 | Immunosuppressant | 0.231 0.165 DBMET02646 | DBMET02646 | |
| 0.03 | 0.175 | 0.096 | Beta adrenoreceptor antagonist | 0.096 0.018 DBMET02646 | DBMET02646 | |
| 0.031 | 0.178 | 0.107 | Purinergic P2X1 antagonist | 0.107 0.014 DBMET02646 | DBMET02646 | |
| 0.028 | 0.177 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.044 DBMET02646 | DBMET02646 | |
| 0.132 | 0.28 | 0.295 | Nitric-oxide synthase stimulant | 0.295 0.013 DBMET02646 | DBMET02646 | |
| 0.121 | 0.271 | 0.235 | Transcription factor STAT3 inhibitor | 0.235 0.097 DBMET02644 0.234 0.097 DBMET02646 0.199 0.135 DBMET02649 | DBMET02644 | |
| 0.018 | 0.168 | 0.132 | NMDA 2 receptor antagonist | 0.079 0.044 DBMET02644 0.132 0.021 DBMET02646 | DBMET02646 | |
| 0.023 | 0.174 | 0.086 | Farnesyltransferase inhibitor | 0.086 0.01 DBMET02646 | DBMET02646 | |
| 0.04 | 0.192 | 0.197 | Urease inhibitor | 0.197 0.01 DBMET02646 | DBMET02646 | |
| 0.004 | 0.158 | 0.024 | Neutral endopeptidase inhibitor | 0.024 0.014 DBMET02649 | DBMET02649 | |
| 0.022 | 0.177 | 0.076 | Aminopeptidase microsomal inhibitor | 0.076 0.027 DBMET02649 | DBMET02649 | |
| 0.015 | 0.17 | 0.055 | Aminopeptidase N inhibitor | 0.055 0.028 DBMET02649 | DBMET02649 | |
| 0.026 | 0.183 | 0.122 | Porphobilinogen synthase inhibitor | 0.122 0.028 DBMET02646 | DBMET02646 | |
| 0.111 | 0.269 | 0.157 | Heat shock protein 70 antagonist | 0.131 0.115 DBMET02644 0.157 0.033 DBMET02646 | DBMET02646 | |
| 0.006 | 0.164 | 0.02 | Kainate receptor 3 antagonist | 0.02 0.009 DBMET02644 | DBMET02644 | |
| 0.054 | 0.213 | 0.139 | Caspase 3 inhibitor | 0.139 0.037 DBMET02649 | DBMET02649 | |
| 0.133 | 0.293 | 0.27 | Insulysin inhibitor | 0.216 0.134 DBMET02646 0.27 0.079 DBMET02649 | DBMET02649 | |
| 0.078 | 0.238 | 0.505 | DNA methyltransferase I inhibitor | 0.145 0.109 DBMET02644 0.505 0.005 DBMET02649 | DBMET02649 | |
| 0.046 | 0.21 | 0.135 | Anabolic | 0.135 0.027 DBMET02646 | DBMET02646 | |
| 0.035 | 0.199 | 0.141 | Ornithine decarboxylase inhibitor | 0.141 0.014 DBMET02646 | DBMET02646 | |
| 0.007 | 0.171 | 0.033 | Glucagon receptor antagonist | 0.033 0.018 DBMET02646 | DBMET02646 | |
| 0.08 | 0.246 | 0.493 | DNA methylase inhibitor | 0.141 0.125 DBMET02644 0.493 0.006 DBMET02649 | DBMET02649 | |
| 0.089 | 0.256 | 0.142 | Sphingosine 1-phosphate receptor 5 antagonist | 0.122 0.121 DBMET02644 0.142 0.076 DBMET02646 | DBMET02646 | |
| 0.007 | 0.174 | 0.037 | HCV NS5B polymerase inhibitor | 0.037 0.017 DBMET02646 | DBMET02646 | |
| 0.01 | 0.177 | 0.047 | Liver X receptor beta agonist | 0.047 0.012 DBMET02646 | DBMET02646 | |
| 0.054 | 0.222 | 0.182 | Thrombolytic | 0.165 0.071 DBMET02646 0.182 0.061 DBMET02649 | DBMET02649 | |
| 0.107 | 0.275 | 0.282 | Thyroid hormone beta antagonist | 0.282 0.098 DBMET02646 | DBMET02646 | |
| 0.062 | 0.232 | 0.368 | Amyloid beta aggregation inhibitor | 0.368 0.03 DBMET02645 | DBMET02645 | |
| 0.02 | 0.19 | 0.079 | Beta 2 adrenoreceptor antagonist | 0.079 0.012 DBMET02646 | DBMET02646 | |
| 0.18 | 0.353 | 0.426 | Caspase 9 stimulant | 0.293 0.202 DBMET02644 0.426 0.096 DBMET02646 | DBMET02646 | |
| 0.105 | 0.278 | 0.296 | Thyroid hormone antagonist | 0.296 0.095 DBMET02646 | DBMET02646 | |
| 0.048 | 0.222 | 0.143 | Beta glucuronidase inhibitor | 0.143 0.029 DBMET02646 | DBMET02646 | |
| 0.059 | 0.233 | 0.13 | Cathepsin H inhibitor | 0.13 0.064 DBMET02646 0.109 0.091 DBMET02649 | DBMET02646 | |
| 0.019 | 0.194 | 0.066 | Beta 1 adrenoreceptor antagonist | 0.066 0.03 DBMET02646 | DBMET02646 | |
| 0.131 | 0.306 | 0.458 | Sodium/bile acid cotransporter inhibitor | 0.458 0.006 DBMET02645 0.203 0.184 DBMET02646 0.255 0.123 DBMET02649 | DBMET02645 | |
| 0.008 | 0.184 | 0.077 | Estrogen agonist | 0.077 0.024 DBMET02646 | DBMET02646 | |
| 0.001 | 0.177 | 0.013 | Insulin like growth factor 3 antagonist | 0.013 0.002 DBMET02646 | DBMET02646 | |
| 0.035 | 0.212 | 0.107 | Alcohol dehydrogenase inhibitor | 0.088 0.067 DBMET02644 0.107 0.046 DBMET02646 | DBMET02646 | |
| 0.019 | 0.196 | 0.06 | Adenylate cyclase 1 inhibitor | 0.06 0.018 DBMET02646 | DBMET02646 | |
| 0.127 | 0.305 | 0.262 | 15-Lipoxygenase inhibitor | 0.248 0.166 DBMET02644 0.262 0.155 DBMET02645 0.211 0.201 DBMET02646 | DBMET02645 | |
| 0.039 | 0.217 | 0.085 | Keratolytic | 0.085 0.043 DBMET02646 | DBMET02646 | |
| 0.021 | 0.201 | 0.083 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.083 0.023 DBMET02646 | DBMET02646 | |
| 0.034 | 0.213 | 0.099 | Glycine receptor antagonist | 0.099 0.033 DBMET02646 | DBMET02646 | |
| 0.046 | 0.229 | 0.093 | Xanthine oxidase inhibitor | 0.093 0.067 DBMET02646 | DBMET02646 | |
| 0.013 | 0.197 | 0.03 | Carboxypeptidase B inhibitor | 0.03 0.029 DBMET02649 | DBMET02649 | |
| 0.013 | 0.196 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DBMET02646 | DBMET02646 | |
| 0.071 | 0.255 | 0.185 | Hexokinase inhibitor | 0.185 0.045 DBMET02646 | DBMET02646 | |
| 0.004 | 0.191 | 0.049 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.049 0.006 DBMET02646 | DBMET02646 | |
| 0.043 | 0.231 | 0.137 | 5 Hydroxytryptamine 3A agonist | 0.1 0.076 DBMET02644 0.137 0.043 DBMET02646 | DBMET02646 | |
| 0.074 | 0.263 | 0.321 | Hepatoprotectant | 0.212 0.058 DBMET02645 0.134 0.128 DBMET02646 0.321 0.024 DBMET02649 | DBMET02649 | |
| 0.07 | 0.26 | 0.405 | Dual specificity phosphatase inhibitor | 0.405 0.014 DBMET02645 | DBMET02645 | |
| 0.049 | 0.239 | 0.206 | Interleukin 5 antagonist | 0.206 0.005 DBMET02649 | DBMET02649 | |
| 0.009 | 0.2 | 0.033 | Catechol O-methyltransferase inhibitor | 0.033 0.022 DBMET02646 | DBMET02646 | |
| 0.011 | 0.204 | 0.08 | Aromatase inhibitor | 0.08 0.028 DBMET02646 | DBMET02646 | |
| 0.113 | 0.31 | 0.264 | Alpha-glucosidase inhibitor | 0.264 0.179 DBMET02646 | DBMET02646 | |
| 0.014 | 0.211 | 0.069 | Bromodomain-containing protein 3 inhibitor | 0.069 0.013 DBMET02646 | DBMET02646 | |
| 0.101 | 0.301 | 0.352 | 12-Lipoxygenase inhibitor | 0.352 0.056 DBMET02646 | DBMET02646 | |
| 0.028 | 0.228 | 0.075 | Glucosylceramidase inhibitor | 0.075 0.019 DBMET02646 | DBMET02646 | |
| 0.014 | 0.218 | 0.049 | Membrane dipeptidase inhibitor | 0.049 0.017 DBMET02649 | DBMET02649 | |
| 0.051 | 0.255 | 0.098 | Microtubule formation inhibitor | 0.098 0.095 DBMET02646 | DBMET02646 | |
| 0.021 | 0.225 | 0.056 | Dopamine beta hydroxylase inhibitor | 0.056 0.02 DBMET02646 | DBMET02646 | |
| 0.01 | 0.214 | 0.061 | Cannabinoid CB2 receptor antagonist | 0.061 0.029 DBMET02646 | DBMET02646 | |
| 0.092 | 0.297 | 0.235 | Beta lactamase inhibitor | 0.235 0.164 DBMET02645 | DBMET02645 | |
| 0.076 | 0.281 | 0.19 | Melanin inhibitor | 0.19 0.045 DBMET02646 | DBMET02646 | |
| 0.083 | 0.295 | 0.245 | Calpain inhibitor | 0.245 0.07 DBMET02645 0.205 0.109 DBMET02649 | DBMET02645 | |
| 0.035 | 0.247 | 0.079 | Sphingosine 1-phosphate receptor antagonist | 0.079 0.048 DBMET02646 | DBMET02646 | |
| 0.07 | 0.285 | 0.141 | Sphingosine 1-phosphate receptor 2 antagonist | 0.141 0.055 DBMET02644 0.137 0.06 DBMET02646 | DBMET02644 | |
| 0.064 | 0.279 | 0.114 | Transcription factor STAT6 inhibitor | 0.114 0.071 DBMET02644 0.114 0.072 DBMET02646 | DBMET02646 | |
| 0.042 | 0.257 | 0.108 | Bile acid receptor antagonist | 0.108 0.034 DBMET02646 | DBMET02646 | |
| 0.007 | 0.228 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | 0.05 0.04 DBMET02649 | DBMET02649 | |
| 0.007 | 0.228 | 0.05 | Ribonucleotide reductase inhibitor | 0.05 0.042 DBMET02649 | DBMET02649 | |
| 0.052 | 0.273 | 0.098 | Photosensitizer | 0.098 0.092 DBMET02646 | DBMET02646 | |
| 0.009 | 0.23 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET02646 | DBMET02646 | |
| 0.011 | 0.233 | 0.05 | Collagenase inhibitor | 0.05 0.033 DBMET02649 | DBMET02649 | |
| 0.013 | 0.236 | 0.055 | Neuraminidase inhibitor | 0.055 0.05 DBMET02649 | DBMET02649 | |
| 0.011 | 0.234 | 0.041 | Oxytocin agonist | 0.041 0.031 DBMET02646 | DBMET02646 | |
| 0.107 | 0.331 | 0.308 | DNA directed DNA polymerase inhibitor | 0.308 0.158 DBMET02645 | DBMET02645 | |
| 0.015 | 0.24 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.024 DBMET02646 | DBMET02646 | |
| 0.047 | 0.272 | 0.118 | Cyclooxygenase inhibitor | 0.118 0.101 DBMET02646 | DBMET02646 | |
| 0.023 | 0.249 | 0.103 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.103 0.036 DBMET02646 | DBMET02646 | |
| 0.043 | 0.27 | 0.107 | Proteasome inhibitor | 0.107 0.079 DBMET02646 0.102 0.084 DBMET02649 | DBMET02646 | |
| 0.053 | 0.284 | 0.082 | CC chemokine 5 receptor agonist | 0.082 0.058 DBMET02646 | DBMET02646 | |
| 0.024 | 0.258 | 0.078 | CDC25A inhibitor | 0.078 0.046 DBMET02645 | DBMET02645 | |
| 0.074 | 0.308 | 0.161 | 3C-like protease (Human coronavirus) inhibitor | 0.161 0.085 DBMET02646 | DBMET02646 | |
| 0.044 | 0.28 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.07 DBMET02646 | DBMET02646 | |
| 0.005 | 0.244 | 0.052 | Carbonic anhydrase I inhibitor | 0.052 0.041 DBMET02646 | DBMET02646 | |
| 0.022 | 0.266 | 0.08 | Sirtuin 1 inhibitor | 0.08 0.035 DBMET02649 | DBMET02649 | |
| 0.053 | 0.299 | 0.195 | Interleukin 4 antagonist | 0.195 0.024 DBMET02646 | DBMET02646 | |
| 0.005 | 0.256 | 0.049 | Carbonic anhydrase II inhibitor | 0.049 0.045 DBMET02646 | DBMET02646 | |
| 0.095 | 0.346 | 0.24 | Transcription factor STAT inhibitor | 0.24 0.094 DBMET02644 0.214 0.119 DBMET02646 | DBMET02644 | |
| 0.018 | 0.27 | 0.113 | Na+ K+ transporting ATPase inhibitor | 0.113 0.02 DBMET02646 | DBMET02646 | |
| 0.024 | 0.278 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.053 DBMET02646 | DBMET02646 | |
| 0.051 | 0.305 | 0.127 | TRPA1 agonist | 0.127 0.051 DBMET02646 | DBMET02646 | |
| 0.043 | 0.297 | 0.095 | Nav1.4 sodium channel blocker | 0.095 0.084 DBMET02649 | DBMET02649 | |
| 0.038 | 0.293 | 0.201 | MAP kinase kinase 1 inhibitor | 0.201 0.005 DBMET02646 | DBMET02646 | |
| 0.052 | 0.307 | 0.122 | Interleukin 8 antagonist | 0.122 0.059 DBMET02646 | DBMET02646 | |
| 0.08 | 0.336 | 0.3 | Cyclic AMP phosphodiesterase inhibitor | 0.3 0.042 DBMET02646 | DBMET02646 | |
| 0.04 | 0.3 | 0.177 | Carbonic anhydrase III inhibitor | 0.177 0.021 DBMET02646 0.113 0.05 DBMET02649 | DBMET02646 | |
| 0.017 | 0.28 | 0.103 | Monophenol monooxygenase inhibitor | 0.103 0.074 DBMET02646 | DBMET02646 | |
| 0.007 | 0.27 | 0.028 | Caspase 2 inhibitor | 0.028 0.025 DBMET02649 | DBMET02649 | |
| 0.024 | 0.29 | 0.07 | Glutamate (mGluR7) antagonist | 0.07 0.043 DBMET02646 | DBMET02646 | |
| 0.07 | 0.338 | 0.177 | CF transmembrane conductance regulator agonist | 0.177 0.039 DBMET02646 | DBMET02646 | |
| 0.017 | 0.285 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET02649 | DBMET02649 | |
| 0.056 | 0.326 | 0.138 | Thiol protease inhibitor | 0.138 0.083 DBMET02649 | DBMET02649 | |
| 0.028 | 0.298 | 0.171 | Potassium channel large-conductance Ca-activated activator | 0.171 0.009 DBMET02646 | DBMET02646 | |
| 0.003 | 0.273 | 0.079 | Estrogen receptor alpha agonist | 0.079 0.012 DBMET02646 | DBMET02646 | |
| 0.02 | 0.295 | 0.065 | Botulinum neurotoxin type A inhibitor | 0.065 0.031 DBMET02646 0.065 0.031 DBMET02649 | DBMET02649 | |
| 0.045 | 0.32 | 0.366 | Angiogenesis stimulant | 0.366 0.029 DBMET02645 0.319 0.042 DBMET02649 | DBMET02645 | |
| 0.072 | 0.35 | 0.216 | 5 Hydroxytryptamine 1E antagonist | 0.216 0.113 DBMET02646 | DBMET02646 | |
| 0.058 | 0.339 | 0.094 | Factor V inhibitor | 0.094 0.085 DBMET02649 | DBMET02649 | |
| 0.018 | 0.299 | 0.125 | Androgen antagonist | 0.125 0.031 DBMET02646 | DBMET02646 | |
| 0.043 | 0.325 | 0.171 | Carbonic anhydrase XV inhibitor | 0.171 0.024 DBMET02646 | DBMET02646 | |
| 0.041 | 0.326 | 0.151 | Pyruvate kinase inhibitor | 0.151 0.114 DBMET02646 | DBMET02646 | |
| 0.143 | 0.431 | 0.64 | Antiinflammatory | 0.422 0.126 DBMET02646 0.64 0.043 DBMET02649 | DBMET02649 | |
| 0.022 | 0.314 | 0.077 | Dihydroorotate oxidase inhibitor | 0.077 0.012 DBMET02646 | DBMET02646 | |
| 0.023 | 0.318 | 0.259 | Potassium channel (Ca-activated) activator | 0.259 0.007 DBMET02646 | DBMET02646 | |
| 0.038 | 0.334 | 0.158 | Aryl hydrocarbon receptor agonist | 0.158 0.129 DBMET02646 | DBMET02646 | |
| 0.017 | 0.314 | 0.058 | Vanilloid 3 antagonist | 0.058 0.005 DBMET02646 | DBMET02646 | |
| 0.016 | 0.313 | 0.099 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.099 0.01 DBMET02646 | DBMET02646 | |
| 0.033 | 0.331 | 0.259 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.259 0.026 DBMET02642 | DBMET02642 | |
| 0.028 | 0.326 | 0.106 | Carbonic anhydrase VI inhibitor | 0.106 0.036 DBMET02646 | DBMET02646 | |
| 0.097 | 0.403 | 0.391 | Antibacterial | 0.391 0.081 DBMET02646 | DBMET02646 | |
| 0.062 | 0.37 | 0.153 | Pregnane X receptor agonist | 0.153 0.048 DBMET02646 | DBMET02646 | |
| 0.004 | 0.313 | 0.072 | Urate transporter 1 inhibitor | 0.072 0.01 DBMET02646 | DBMET02646 | |
| 0.072 | 0.384 | 0.227 | DNA polymerase beta inhibitor | 0.227 0.206 DBMET02645 | DBMET02645 | |
| 0.083 | 0.398 | 0.242 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.242 0.046 DBMET02646 | DBMET02646 | |
| 0.061 | 0.38 | 0.212 | Growth hormone agonist | 0.212 0.054 DBMET02649 | DBMET02649 | |
| 0.049 | 0.369 | 0.251 | Nitric oxide antagonist | 0.163 0.085 DBMET02646 0.251 0.051 DBMET02649 | DBMET02649 | |
| 0.02 | 0.352 | 0.084 | Protein kinase C zeta inhibitor | 0.084 0.078 DBMET02646 | DBMET02646 | |
| 0.004 | 0.337 | 0.036 | Glutamate (mGluR group II) antagonist | 0.036 0.029 DBMET02646 | DBMET02646 | |
| 0.007 | 0.342 | 0.032 | Nicotinic acid receptor agonist | 0.032 0.03 DBMET02646 | DBMET02646 | |
| 0.012 | 0.348 | 0.107 | Androgen agonist | 0.107 0.012 DBMET02646 | DBMET02646 | |
| 0.018 | 0.356 | 0.093 | Carbonic anhydrase XIII inhibitor | 0.093 0.042 DBMET02646 | DBMET02646 | |
| 0.021 | 0.36 | 0.089 | Protease inhibitor | 0.089 0.075 DBMET02649 | DBMET02649 | |
| 0.006 | 0.346 | 0.029 | Geranylgeranyltransferase I inhibitor | 0.029 0.009 DBMET02646 | DBMET02646 | |
| 0.019 | 0.363 | 0.074 | Aryl hydrocarbon receptor antagonist | 0.074 0.033 DBMET02646 | DBMET02646 | |
| 0.002 | 0.35 | 0.022 | Nicotinic acid receptor 1 antagonist | 0.022 0.007 DBMET02646 | DBMET02646 | |
| 0.027 | 0.383 | 0.129 | Alkaline phosphatase inhibitor | 0.129 0.076 DBMET02646 | DBMET02646 | |
| 0.006 | 0.368 | 0.053 | Carbonic anhydrase VB inhibitor | 0.053 0.042 DBMET02646 | DBMET02646 | |
| 0.04 | 0.405 | 0.264 | Farnesoid X receptor antagonist | 0.264 0.009 DBMET02645 0.134 0.075 DBMET02646 | DBMET02645 | |
| 0.032 | 0.396 | 0.09 | MAP kinase kinase 7 inhibitor | 0.09 0.024 DBMET02646 | DBMET02646 | |
| 0.122 | 0.499 | 0.349 | Calcium channel L-type activator | 0.349 0.118 DBMET02646 | DBMET02646 | |
| 0.018 | 0.398 | 0.076 | Topoisomerase II beta inhibitor | 0.076 0.014 DBMET02646 | DBMET02646 | |
| 0.037 | 0.421 | 0.083 | Transcription factor NF kappa B stimulant | 0.083 0.063 DBMET02649 | DBMET02649 | |
| 0.04 | 0.43 | 0.324 | Antiamyloidogenic | 0.324 0.045 DBMET02645 0.208 0.094 DBMET02646 0.283 0.057 DBMET02649 | DBMET02645 | |
| 0.002 | 0.393 | 0.04 | Alpha 2a adrenoreceptor agonist | 0.04 0.004 DBMET02646 | DBMET02646 | |
| 0.013 | 0.404 | 0.061 | Carbonic anhydrase VA inhibitor | 0.061 0.058 DBMET02646 | DBMET02646 | |
| 0.027 | 0.42 | 0.053 | Immunoglobulin Fc receptor antagonist | 0.053 0.047 DBMET02646 | DBMET02646 | |
| 0.015 | 0.41 | 0.042 | DNA gyrase subunit A inhibitor | 0.042 0.029 DBMET02649 | DBMET02649 | |
| 0.003 | 0.4 | 0.073 | Estrogen receptor beta agonist | 0.073 0.015 DBMET02646 | DBMET02646 | |
| 0.006 | 0.406 | 0.04 | HIV-1 protease inhibitor | 0.04 0.034 DBMET02649 | DBMET02649 | |
| 0.003 | 0.406 | 0.052 | Carbonic anhydrase XII inhibitor | 0.052 0.037 DBMET02646 | DBMET02646 | |
| 0.04 | 0.448 | 0.096 | Hematopoietic | 0.096 0.041 DBMET02649 | DBMET02649 | |
| 0.013 | 0.432 | 0.05 | Purinergic P2X4 antagonist | 0.05 0.024 DBMET02646 | DBMET02646 | |
| 0.003 | 0.429 | 0.062 | Carbonic anhydrase IX inhibitor | 0.062 0.036 DBMET02646 | DBMET02646 | |
| 0.01 | 0.44 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 DBMET02649 | DBMET02649 | |
| 0.008 | 0.455 | 0.101 | Bromodomain-containing protein 4 inhibitor | 0.101 0.013 DBMET02646 | DBMET02646 | |
| 0.003 | 0.45 | 0.059 | Progesterone antagonist | 0.059 0.015 DBMET02646 | DBMET02646 | |
| 0.009 | 0.468 | 0.103 | Maillard reaction inhibitor | 0.103 0.016 DBMET02646 | DBMET02646 | |
| 0.015 | 0.476 | 0.091 | Transcription factor AP-1 inhibitor | 0.091 0.016 DBMET02646 | DBMET02646 | |
| 0.011 | 0.479 | 0.092 | CYP2A6 inhibitor | 0.092 0.04 DBMET02646 | DBMET02646 | |
| 0.01 | 0.48 | 0.11 | Potassium channel (ATP-sensitive) activator | 0.11 0.004 DBMET02646 | DBMET02646 | |
| 0.01 | 0.484 | 0.113 | Potassium channel (Inward rectifier) activator | 0.113 0.004 DBMET02646 | DBMET02646 | |
| 0.012 | 0.52 | 0.277 | MAP kinase kinase inhibitor | 0.277 0.011 DBMET02646 | DBMET02646 | |
| 0.041 | 0.557 | 0.123 | NOS3 expression enhancer | 0.123 0.109 DBMET02646 | DBMET02646 | |
| 0.005 | 0.535 | 0.06 | Dihydroorotate dehydrogenase inhibitor | 0.06 0.028 DBMET02646 | DBMET02646 | |
| 0.022 | 0.562 | 0.493 | Interleukin antagonist | 0.185 0.093 DBMET02646 0.493 0.02 DBMET02649 | DBMET02649 | |
| 0.009 | 0.567 | 0.106 | M17 leucyl aminopeptidase inhibitor | 0.106 0.093 DBMET02649 | DBMET02649 | |
| 0.007 | 0.566 | 0.085 | HIV-1 reverse transcriptase inhibitor | 0.085 0.039 DBMET02646 | DBMET02646 | |
| 0.004 | 0.567 | 0.297 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.297 0.003 DBMET02646 | DBMET02646 | |
| 0.01 | 0.58 | 0.164 | Topoisomerase II inhibitor | 0.164 0.043 DBMET02649 | DBMET02649 | |
| 0.01 | 0.596 | 0.166 | Potassium channel activator | 0.166 0.015 DBMET02646 | DBMET02646 | |
| 0.013 | 0.6 | 0.108 | Beta amyloid protein antagonist | 0.108 0.079 DBMET02646 | DBMET02646 | |
| 0.024 | 0.624 | 0.161 | Histone deacetylase SIRT1 inhibitor | 0.161 0.053 DBMET02649 | DBMET02649 | |
| 0.012 | 0.617 | 0.16 | M18 aspartyl aminopeptidase inhibitor | 0.16 0.047 DBMET02646 | DBMET02646 | |
| 0.007 | 0.614 | 0.077 | Lipase inhibitor | 0.077 0.046 DBMET02649 | DBMET02649 | |
| 0.021 | 0.632 | 0.122 | Interleukin 1 antagonist | 0.122 0.085 DBMET02646 | DBMET02646 | |
| 0.008 | 0.628 | 0.128 | Tubulin antagonist | 0.128 0.073 DBMET02646 | DBMET02646 | |
| 0.014 | 0.636 | 0.128 | Factor IXa inhibitor | 0.128 0.005 DBMET02646 | DBMET02646 | |
| 0.005 | 0.627 | 0.054 | NMDA 2B receptor antagonist | 0.054 0.037 DBMET02646 | DBMET02646 | |
| 0.013 | 0.654 | 0.111 | Histone deacetylase class III inhibitor | 0.111 0.079 DBMET02649 | DBMET02649 | |
| 0.004 | 0.645 | 0.042 | Kinesin-like protein 1 inhibitor | 0.042 0.02 DBMET02649 | DBMET02649 | |
| 0.004 | 0.645 | 0.042 | Kinesin antagonist | 0.042 0.02 DBMET02649 | DBMET02649 | |
| 0.015 | 0.659 | 0.077 | Ca(v)3.2 blocker | 0.077 0.017 DBMET02646 | DBMET02646 | |
| 0.069 | 0.768 | 0.395 | MAP kinase kinase 3 inhibitor | 0.395 0.003 DBMET02646 | DBMET02646 | |
| 0.021 | 0.73 | 0.189 | Histone acetyltransferase inhibitor | 0.189 0.086 DBMET02646 | DBMET02646 | |
| 0.037 | 0.754 | 0.281 | MAP kinase kinase 4 inhibitor | 0.281 0.004 DBMET02646 | DBMET02646 | |
| 0.005 | 0.732 | 0.389 | Check point kinase 2 inhibitor | 0.389 0.004 DBMET02646 | DBMET02646 | |
| 0.004 | 0.798 | 0.095 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.095 0.038 DBMET02646 | DBMET02646 | |
| 0.004 | 0.802 | 0.177 | Alpha tubulin antagonist | 0.177 0.007 DBMET02646 | DBMET02646 | |
| 0.003 | 0.856 | 0.029 | Glucocorticoid antagonist | 0.029 0.024 DBMET02646 | DBMET02646 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |